Adviser
Tungsten Advisors.
Financial adviser on 3 live deals, from 14 Mar 2024 to 6 Aug 2026.
03Live deals
04Other advisers
Deals
| Date | Deal | Stage | Role | Sector |
|---|---|---|---|---|
| 6 Aug 2026 | Ensysce Biosciences, Inc. / Cy Biopharma, Inc. | Closed |
| Not stated |
| 29 Jul 2026 | Processa Pharmaceuticals, Inc. / Vidya Therapeutics, Inc. | Agreement signed |
| Not stated |
| 14 Mar 2024 | First Wave BioPharma, Inc. / ImmunogenX | Closed |
| Healthcare |
By year, sector and stage
| 2026 | 2 |
|---|---|
| 2024 | 1 |
| Not stated | 2 |
|---|---|
| Healthcare | 1 |
| Closed | 2 |
|---|---|
| Agreement signed | 1 |
Other advisers on the same deals
| Adviser | Shared deals | Across the table | Alongside |
|---|---|---|---|
| Orrick, Herrington & Sutcliffe LLP | 1 | 1 | 0 |
| Wedbush Securities Inc. | 1 | 1 | 0 |
| Katten Muchin Rosenman LLP | 1 | 0 | 1 |
| Troutman Pepper Locke LLP | 1 | 0 | 1 |